Sanofi takes another stab at injunction in injector pen patent case
Appeals 2019-01-04 9:08 pmBy Cat Fredenburgh | Melbourne
Please login to bookmark Close

French pharmaceutical giant Sanofi has appealed a judge’s ruling denying its bid to block Alphapharm from listing an insulin injector pen on the Pharmaceutical Benefit Scheme.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au